Figure 1.
![Gut microbiota alpha diversity of patients with PV, of the different PV treatment groups, and of HCs. (A) Gut microbiota alpha diversity (median Inverse Simpson Index [InvSimpson]) of HCs and patients with PV. Alpha diversity differed significantly between patients with PV (median InvSimpson, 20.2) and HCs (median InvSimpson, 26.3) (P = .016). (B) Alpha diversity (InvSimpson) of HCs, COMBI, HU, IFN-α2, and NT group. After adjusting for multiple testing, no significant difference was found.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/13/10.1182_bloodadvances.2022008555/1/blooda_adv-2022-008555-gr1.jpeg?Expires=1724958573&Signature=visdoxuAeicrFlyBr12bGSacm702raVmpM5DYvq17cnwBLlO2u6BbEsTMfn6Tdr2NZ~l23y4iksBOLKZNgcU-D1ZUJUZw9Ij1h7pfmWOWUMyCFWBN68ZQ6wZxUUXuVZAYSez4uGnol~DnvsSar1-eaEomF6v4m8696Bv0aFWYX2WpPXbg37-fAztPgkWFY2h5bHBZQZqN2wwugYf00fRyG9vtrdgiA7KShzqNHVsBWVNdDLzlTvwU2zST7xbsr18Q0FyIYuWHoFGDVwAeLeQ7V-3jmqkmV79KvL0ZDySUJFAH0sJloV~gbbyxEybwKsU2FoVSzOsDZrlPcxvb2Ek~A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Gut microbiota alpha diversity of patients with PV, of the different PV treatment groups, and of HCs. (A) Gut microbiota alpha diversity (median Inverse Simpson Index [InvSimpson]) of HCs and patients with PV. Alpha diversity differed significantly between patients with PV (median InvSimpson, 20.2) and HCs (median InvSimpson, 26.3) (P = .016). (B) Alpha diversity (InvSimpson) of HCs, COMBI, HU, IFN-α2, and NT group. After adjusting for multiple testing, no significant difference was found.
